I don't know the answer (off the top of my head) but I am pretty sure they were talking about it on Shire's last CC (or Investor Conference maybe Cowen?). I occasionally listen to their calls to find out how the Rare Disease side of their business is progressing. I guess you don't give credit for knowing where to find the answer?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.